Androgenic alopecia - I-Androgenic Alopeciahttps://en.wikipedia.org/wiki/Pattern_hair_loss
I- I-Androgenic Alopecia (Androgenic alopecia) ukuqothuka kwezinwele okuthinta ngokuyinhloko phezulu nangaphambili kwesikhumba sekhanda. Ekulahlekeni kwezinwele okuyiphethini yabesilisa (MPHL), ukulahleka kwezinwele kuvame ukuziveza njengokuhlehla kwezinwele zangaphambili, ukulahleka kwezinwele ku-vertex yesikhumba, noma inhlanganisela yakho kokubili. Ukulahleka kwezinwele okuyiphethini yabesifazane (i-FPHL) kuvame ukwethula njengokuzaca okusabalele kwezinwele kuso sonke isikhumba sekhanda.

Ukulahleka kwezinwele zephethini yesilisa kubonakala kubangelwa inhlanganisela yofuzo nama-androgens ajikelezayo, ikakhulukazi i-dihydrotestosterone (DHT). Isizathu sokuqothuka kwezinwele zephethini yabesifazane akukacaci.

Ukwelashwa okuvamile kubandakanya i-minoxidil, i-finasteride, i-dutasteride, noma ukuhlinzwa kokufakelwa izinwele. Ukusetshenziswa kwe-finasteride ne-dutasteride kwabesifazane abakhulelwe kungase kubangele ukukhubazeka kokuzalwa.

Ukwelashwa
I-Finasteride ne-dutasteride zisebenza kahle kakhulu kwabesilisa nakwabesifazane abangemuva kokumenopausal. I-minoxydil yomlomo enedosi ephansi ingase isetshenziselwe izimo ezimbalwa ezikhethiwe.
#Finasteride
#Dutasteride

Ukwelashwa - Izidakamizwa ze-OTC
Emazweni amaningi, amalungiselelo e-topical minoxidil atholakala ngaphandle kwe-counter. Kukhona ezinye izithasiselo ezithi ziyasebenza ekulweni nokuqothuka kwezinwele, kodwa eziningi azikafakazelwa ngokwesayensi ukuthi ziyasebenza.
#5% minoxidil
☆ Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
  • Male-pattern hair loss
    References Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics 34741573 
    NIH
    Although topical minoxidil, oral finasteride, and low‐level light therapy are the only FDA‐approved therapies to treat AGA, they are just a fraction of the treatment options available, including other oral and topical modalities, hormonal therapies, nutraceuticals, PRP and exosome treatments, and hair transplantation.